Study protocol- Lumbar Epidural steroid injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults.

Comparative Effectiveness, Cost and Outcomes Research Center, University of Washington, Seattle, USA.
BMC Musculoskeletal Disorders (Impact Factor: 1.88). 03/2012; 13:48. DOI: 10.1186/1471-2474-13-48
Source: PubMed

ABSTRACT Lumbar spinal stenosis is one of the most common causes of low back pain among older adults and can cause significant disability. Despite its prevalence, treatment of spinal stenosis symptoms remains controversial. Epidural steroid injections are used with increasing frequency as a less invasive, potentially safer, and more cost-effective treatment than surgery. However, there is a lack of data to judge the effectiveness and safety of epidural steroid injections for spinal stenosis. We describe our prospective, double-blind, randomized controlled trial that tests the hypothesis that epidural injections with steroids plus local anesthetic are more effective than epidural injections of local anesthetic alone in improving pain and function among older adults with lumbar spinal stenosis.
We will recruit up to 400 patients with lumbar central canal spinal stenosis from at least 9 clinical sites over 2 years. Patients with spinal instability who require surgical fusion, a history of prior lumbar surgery, or prior epidural steroid injection within the past 6 months are excluded. Participants are randomly assigned to receive either ESI with local anesthetic or the control intervention (epidural injections with local anesthetic alone). Subjects receive up to 2 injections prior to the primary endpoint at 6 weeks, at which time they may choose to crossover to the other intervention.Participants complete validated, standardized measures of pain, functional disability, and health-related quality of life at baseline and at 3 weeks, 6 weeks, and 3, 6, and 12 months after randomization. The primary outcomes are Roland-Morris Disability Questionnaire and a numerical rating scale measure of pain intensity at 6 weeks. In order to better understand their safety, we also measure cortisol, HbA1c, fasting blood glucose, weight, and blood pressure at baseline, and at 3 and 6 weeks post-injection. We also obtain data on resource utilization and costs to assess cost-effectiveness of epidural steroid injection.
This study is the first multi-center, double-blind RCT to evaluate the effectiveness of epidural steroid injections in improving pain and function among older adults with lumbar spinal stenosis. The study will also yield data on the safety and cost-effectiveness of this procedure for older adults. NCT01238536.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Study Design. Retrospective observational cohort analysis of administrative claims.Objective. Estimate readmission rates following spine stenosis decompression surgery in a 5% randomly selected sample of Medicare beneficiaries.Summary of Background Data. Operative management of lumbar spinal stenosis has significant and measurable benefits compared with non-operative care. Revision rates for lumbar decompression with and without fusion have been reported with significant variability. An understanding of readmission and re-operation rates informs decisions regarding the cost-effective management of lumbar stenosis.Methods. Patients were identified in 2005-2009 Medicare claims who had both a procedure code for decompression (03.09), and a diagnosis of lumbar spinal stenosis (724.02). Patients diagnosed with spondylolisthesis, and those receiving revision surgery or fusion of more than 3 segments were excluded. Kaplan-Meier product limit method was used to estimate univariate rates of readmission for fusion, decompression or injection and Cox proportional hazards to examine whether fusion decreased the likelihood of readmission.Results. The overall 1-year readmission rate was slightly higher in patients undergoing fusion with decompression (9.7%) than patients who underwent decompression alone (7.2%, p = 0.03). Rates at 2-years were 14.6 and 12.5% respectively. Patients receiving decompression with fusion were slightly younger and more likely female. Procedures performed during readmission were similar for the fusion and no fusion cohorts with 56% receiving fusion, 23% decompression and 22% injection for pain management. Of the patients who were not readmitted, >25% of patients received outpatient injections for pain management during the 3 month-quarter of their surgery and ∼20% in the subsequent quarter.Conclusion. Re-admission rates for spinal stenosis decompression were approximately 8-10% per year. Fusion at the index procedure did not protect against subsequent readmission. Large databases can inform choice of surgical options by focusing examination on indications for surgery and reasons for readmission. Fusion along with decompression does not seem to impact readmission rates.
    Spine 01/2013; · 2.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Most clinical guidelines do not recommend routine use of epidural steroid injections for the management of chronic low back pain. However, many clinicians do not adhere to these guidelines. This comprehensive evidence overview concluded that off-label epidural steroid injections provide small short-term but not long- term leg-pain relief and improvement in function; injection of steroids is no more effective than injection of local anesthetics alone; post-procedural complications are uncommon, but the risk of contamination and serious infections is very high. The evidence does not support routine use of off-label epidural steroid injections in adults with benign radicular lumbosacral pain.
    Physical Medicine and Rehabilitation Clinics of North America 05/2014; 25(2):471-489.e50. · 1.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Multicenter Osteoarthritis Study (MOST) is a longitudinal observational study of the effects of biomechanical, bone and joint structural, and nutritional factors on the incidence and progression of knee symptoms and radiographic and symptomatic knee osteoarthritis (OA). It is the first large-scale epidemiologic study to focus on symptomatic knee OA in a community-based sample of adults with or at high risk for knee OA based on the presence of knee symptoms, history of knee injury or surgery, or being overweight. Beginning in 2003, 3026 individuals (60.1% women) aged 50-79 years were enrolled. Examinations at baseline and 15, 30, 60, 72, and 84 months later included assessment of risk factors, disease characteristics, body functions and structure, and measures of physical activity and participation. The wealth of data from this longitudinal cohort of community-dwelling older adults affords valuable opportunities for rehabilitation researchers.
    PM&R 08/2013; 5(8):647-54. · 1.37 Impact Factor

Full-text (2 Sources)

Available from
May 19, 2014